PART I Overview We are a biotechnology company focused on developing a new class of genetic medicines designed to provide durable, and potentially curative, treatment options for patients with diseases driven by defined genetic alterations, acquired cellular dysfunction, or dysregulated gene expression. Our approach is grounded in Prime Editing, a next-generation gene editing technology that enables targeted modifications to genomic DNA without introducing double-stranded breaks. We believe Prim...
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-03 | 2025-12-31 | 0001628280-26-013569 | EDGAR | 132K words |
| 2025-02-28 | 2024-12-31 | 0001628280-25-008884 | EDGAR | — |
| 2024-03-01 | 2023-12-31 | 0001628280-24-008116 | EDGAR | — |
| 2023-03-09 | 2022-12-31 | 0001628280-23-007266 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-06 | 2026-06-30 | 0001628280-26-053883 | EDGAR | — |
| 2025-11-07 | 2025-09-30 | 0001628280-25-050422 | EDGAR | 20K words |
| 2025-08-07 | 2025-06-30 | 0001628280-25-038619 | EDGAR | — |
| 2025-05-08 | 2025-03-31 | 0001628280-25-023486 | EDGAR | — |
| 2024-11-12 | 2024-09-30 | 0001628280-24-047130 | EDGAR | — |
| 2024-08-08 | 2024-06-30 | 0001628280-24-035893 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0001628280-24-022473 | EDGAR | — |
| 2023-11-03 | 2023-09-30 | 0001628280-23-036777 | EDGAR | — |
| 2023-08-07 | 2023-06-30 | 0001628280-23-027772 | EDGAR | — |
| 2023-05-11 | 2023-03-31 | 0001628280-23-017423 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001628280-22-029889 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-08-06 | 0001628280-26-053878 | EDGAR | — |
| 2026-03-03 | 0001628280-26-013565 | EDGAR | 2K words |
| 2026-01-12 | 0001628280-26-001773 | EDGAR | — |
| 2025-11-07 | 0001628280-25-050415 | EDGAR | — |
| 2025-09-08 | 0001894562-25-000056 | EDGAR | — |
| 2025-08-07 | 0001628280-25-038617 | EDGAR | — |
| 2025-08-05 | 0001628280-25-037840 | EDGAR | — |
| 2025-07-31 | 0001628280-25-037076 | EDGAR | — |
| 2025-07-30 | 0001628280-25-036705 | EDGAR | — |
| 2025-07-15 | 0001628280-25-034971 | EDGAR | — |
67 total filings indexed. 42 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001894562 |
| Ticker | PRME |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Website | https://www.primemedicine.com |
| Listed | 2022-10-20 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/PRME (~200 tokens, structured JSON with cryptographic provenance)